H.C. Wainwright Reiterates Buy Rating on AnaptysBio (ANAB)

October 15, 2025 7:24 AM UTC Send to a Friend
H.C. Wainwright analyst Emily Bodnar reiterated a Buy rating and $59.00 price target on AnaptysBio (NASDAQ: ANAB).The analyst commented: "Yesterday ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login